The DOI matches its Crossref record; 865 of the 865 references it cites were found in a registry or an index.
Strategies to Address Low Drug Solubility in Discovery and Development
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–600 of 865
Preclinical formulations for discovery and toxicology: physicochemical challenges
Neervannan, S. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.5.715 · Cited by 164
Silica-lipid hybrid (SLH) microcapsules: A novel oral delivery system for poorly soluble drugs
Tan, A., Simovic, S., Davey, A. K., Rades, T., & Prestidge, C. A. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.014 · Cited by 163
Vandecruys, R., Peeters, J., Verreck, G., & Brewster, M. E. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.006 · Cited by 163
Paudel, A., Humbeeck, J. V., & den Mooter, G. V. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100013p · Cited by 162
Passerini, N., Albertini, B., Perissutti, B., & Rodriguez, L. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.028 · Cited by 162
Verheyen, S., Blaton, N., Kinget, R., & Van den Mooter, G. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00532-x · Cited by 162
Design of Potent Amorphous Drug Nanoparticles for Rapid Generation of Highly Supersaturated Media
Matteucci, M. E., Brettmann, B. K., Rogers, T. L., Elder, E. J., Williams, R. O., & Johnston, K. P. (2007) · Molecular Pharmaceutics · doi:10.1021/mp0700211 · Cited by 162
Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers
Ingels, F., Beck, B., Oth, M., & Augustijns, P. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.014 · Cited by 162
Mechanisms of cellular uptake of long chain free fatty acids
Berk, P. D., & Stump, D. D. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006832001033 · Cited by 161
Supersaturating Drug Delivery Systems: Fast is Not Necessarily Good Enough
Augustijns, P., & Brewster, M. E. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22750 · Cited by 161
Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement
Murdande, S. B., Pikal, M. J., Shanker, R. M., & Bogner, R. H. (2010) · Pharmaceutical Development and Technology · doi:10.3109/10837451003774377 · Cited by 160
Self-citationEffects of Pluronic Block Copolymers on Drug Absorption in Caco-2 Cell Monolayers
Batrakova, E. V., Han, H.-Y., Alakhov, V. Y., Miller, D. W., & Kabanov, A. V. (1998) · Pharmaceutical Research · doi:10.1023/a:1011964213024 · Cited by 159
Preparation and Characterization of Quercetin Nanocrystals
Sahoo, N. G., Kakran, M., Shaal, L. A., Li, L., Müller, R. H., Pal, M., & Tan, L. P. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22446 · Cited by 159
Miller, D. A., DiNunzio, J. C., Yang, W., McGinity, J. W., & Williams, R. O. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040801929273 · Cited by 159
Microsomal Triglyceride Transfer Protein
Jamil, H., Dickson, J. K., Chu, C.-H., Lago, M. W., Rinehart, J. K., Biller, S. A., Gregg, R. E., & Wetterau, J. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6549 · Cited by 158
Luo, C.-F., Yuan, M., Chen, M.-S., Liu, S.-M., Zhu, L., Huang, B.-Y., Liu, X.-W., & Xiong, W. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.064 · Cited by 158
Intestinal absorption of long-chain fatty acids: Evidence and uncertainties
Niot, I., Poirier, H., Tran, T. T. T., & Besnard, P. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.01.001 · Cited by 158
Moneghini, M., Kikic, I., Voinovich, D., Perissutti, B., & Filipović‐Grčić, J. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00711-6 · Cited by 157
Cuiné, J. F., Charman, W. N., Pouton, C. W., Edwards, G. A., & Porter, C. J. H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9194-z · Cited by 157
Self-citationHurter, P. N., Scheutjens, J. M. H. M., & Hatton, T. A. (1993) · Macromolecules · doi:10.1021/ma00073a010 · Cited by 156
Agüeros, M., Zabaleta, V., Espuelas, S., Campanero, M. A., & Irache, J. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.012 · Cited by 156
Pharmacokinetics of halofantrine in man: effects of food and dose size.
Milton, K. A., Edwards, G., Ward, S. A., Orme, M., & Breckenridge, A. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03507.x · Cited by 156
Thermodynamics of Micelle Formation: Prediction of Micelle Size and Size Distribution
Tanford, C. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.5.1811 · Cited by 156
Anby, M. U., Williams, H. D., McIntosh, M. P., Benameur, H., Edwards, G. A., Pouton, C. W., & Porter, C. J. H. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300164u · Cited by 156
Self-citationSolubility: it's not just for physical chemists
Bhattachar, S., Deschenes, L. A., & Wesley, J. A. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.09.002 · Cited by 155
Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat
Rabinow, B. E., Kipp, J., Papadopoulos, P., Wong, J., Glosson, J., Gass, J. H., Sun, C.-S., Wielgos, T., White, R., Cook, C. S., et al. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.02.030 · Cited by 155
Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents
Kawakami, K., Oda, N., Miyoshi, K., Funaki, T., & Ida, Y. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.012 · Cited by 154
Drug/Cyclodextrin/Hydroxy Acid Multicomponent Systems. Properties and Pharmaceutical Applications
Redenti, E., Szente, L., & Szejtli, J. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200001)89:1<1::aid-jps1>3.0.co;2-w · Cited by 154
Klein, C. E., Chiu, Y., Awni, W. M., Zhu, T., HEUSER, R. S., Doan, T., Breitenbach, J., Morris, J. B., Brun, S. C., & Hanna, G. J. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31803133c5 · Cited by 153
Miyazaki, T., Yoshioka, S., Aso, Y., & Kojima, S. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20182 · Cited by 152
Kennedy, M. T., Hu, J., Gao, P., Li, L., Ali-Reynolds, A., Chal, B., Gupta, V., Ma, C., Mahajan, N., Akrami, A., et al. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800061r · Cited by 152
Interpretation of Relaxation Time Constants for Amorphous Pharmaceutical Systems
Shamblin, S. L., Hancock, B. C., Dupuis, Y., & Pikal, M. J. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200003)89:3<417::aid-jps12>3.0.co;2-v · Cited by 152
Sassene, P. J., Knopp, M. M., Hesselkilde, J. Z., Koradia, V., Larsen, A. T., Rades, T., & Müllertz, A. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22226 · Cited by 151
Khoo, S., Shackleford, D. M., Porter, C. J. H., Edwards, G. A., & Charman, W. N. (2003) · Pharmaceutical Research · doi:10.1023/a:1025718513246 · Cited by 150
Self-citationOxidized Mesoporous Silicon Microparticles for Improved Oral Delivery of Poorly Soluble Drugs
Wang, F., He, H. Z., Barnes, T. J., Barnett, C., & Prestidge, C. A. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900221e · Cited by 150
Morphological observations on a lipid-based drug delivery system during in vitro digestion
Fatouros, D. G., Bergenståhl, B., & Müllertz, A. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.02.009 · Cited by 150
Larsen, A. T., Sassene, P. J., & Müllertz, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.03.002 · Cited by 150
Zia, V., Rajewski, R. A., & Stella, V. J. (2001) · Pharmaceutical Research · doi:10.1023/a:1011041628797 · Cited by 149
Confocal Raman-Spectroscopy: Analytical Approach to Solid Dispersions and Mapping of Drugs
Breitenbach, J., Schrof, W., & Neumann, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018956304595 · Cited by 149
Junquera, E., Tardajos, G., & Aicart, E. (1993) · Langmuir · doi:10.1021/la00029a011 · Cited by 149
A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel
Yang, Y., Wang, J., Zhang, X., Lü, W.-L., & Zhang, Q. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.007 · Cited by 148
Serajuddin, A. T. M., & Jarowski, C. I. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740209 · Cited by 148
Dollo, G., Corre, P. L., Guérin, A., Chevanne, F., Burgot, J. L., & Verge, R. L. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00134-9 · Cited by 148
Sheng, J. J., Kasim, N. A., Ramachandran, C., & Amidon, G. L. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.06.006 · Cited by 148
Amphiphilic block copolymer micelles for nanoscale drug delivery
Kwon, G. S., & Forrest, M. L. (2006) · Drug Development Research · doi:10.1002/ddr.20063 · Cited by 146
Engineering of Pharmaceutical Materials: An Industrial Perspective
Chow, K., Tong, H. H. Y., Lum, S., & Chow, A. H. L. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21212 · Cited by 146
Phase Behavioral Effects on Particle Formation Processes Using Supercritical Fluids
Palakodaty, S., & York, P. (1999) · Pharmaceutical Research · doi:10.1023/a:1011957512347 · Cited by 144
Synergistic effect of PEG-400 and cyclodextrin to enhance solubility of progesterone
Nandi, I., Bateson, M., Bari, M., & Joshi, H. (2003) · AAPS PharmSciTech · doi:10.1208/pt040101 · Cited by 144
Electrospun Nanofibers in Oral Drug Delivery
Ignatious, F., Sun, L., Lee, C.-P., & Baldoni, J. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0061-6 · Cited by 144
Suresh, G., Manjunath, K., Venkateswarlu, V., & Satyanarayana, V. (2007) · AAPS PharmSciTech · doi:10.1208/pt0801024 · Cited by 144
Kapsi, S. G., & Ayres, J. W. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00867-5 · Cited by 143
Understanding the Effect of API Properties on Bioavailability Through Absorption Modeling
Kesisoglou, F., & Wu, Y. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9061-4 · Cited by 143
Solid self-emulsifying nitrendipine pellets: Preparation and in vitro/in vivo evaluation
Wang, Z., Sun, J., Wang, Y., Liu, X., Liu, Y., Fu, Q., Meng, P., & He, Z. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.08.014 · Cited by 143
Mechanisms maintaining a low-pH microclimate in the intestine
Shiau, Y. F., Fernández, P., Jackson, M. J., & McMonagle, S. (1985) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1985.248.6.g608 · Cited by 143
SUZUKI, H., & Sunada, H. (1998) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.46.482 · Cited by 142
Predicting Intestinal Precipitation—A Case Example for a Basic BCS Class II Drug
Carlert, S., Pålsson, A., Hanisch, G., von Corswant, C., Nilsson, C. A. M., Lindfors, L., Lennernäs, H., & Abrahamsson, B. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0213-8 · Cited by 141
Armstrong, J. K., Chowdhry, B. Z., Mitchell, J. C., et al. (1996) · The Journal of Physical Chemistry · doi:10.1021/jp951390s · Cited by 141
Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability
Charman, W. N., Rogge, M. C., Boddy, A. W., & Berger, B. M. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb04673.x · Cited by 141
Self-citationSchöler, N., Krause, K., Kayser, O., Müller, R. H., Borner, K., Hahn, H. H., & Liesenfeld, O. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1771-1779.2001 · Cited by 140
Correlating thermodynamic and kinetic parameters with amorphous stability
Graeser, K. A., Patterson, J. E., Zeitler, J. A., Gordon, K. C., & Rades, T. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.04.005 · Cited by 140
Pharmaceutical evaluation of early development candidates “the 100 mg-approach”
Balbach, S., & Korn, C. B. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.034 · Cited by 139
Kadam, Y., Yerramilli, U., & Bahadur, A. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.03.027 · Cited by 138
Physical Chemical Considerations of Lipid-Based Oral Drug Delivery-Solid Lipid Nanoparticles
Bummer, P. M. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i1.10 · Cited by 137
Speybroeck, M. V., Mols, R., Mellaerts, R., Thi, T. D., Martens, J. A., Humbeeck, J. V., Annaert, P., den Mooter, G. V., & Augustijns, P. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.04.009 · Cited by 136
Gu, C., Rao, D. A., Gandhi, R. B., Hilden, J. O. N., & Raghavan, K. S. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20242 · Cited by 136
Jia, L., Zhang, D., Li, Z., Duan, C., Wang, Y., Feng, F., Wang, F., Liu, Y., & Zhang, Q. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.06.008 · Cited by 136
Formulation-Related Problems Associated with Intravenous Drug Delivery
Yalkowsky, S. H., Krzyzaniak, J. F., & Ward, G. H. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980051i · Cited by 136
Prajapati, H. N., Dalrymple, D. M., & Serajuddin, A. T. M. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0541-3 · Cited by 136
Oral solid gentamicin preparation using emulsifier and adsorbent
Ιtο, Y., Kusawake, T., Ishida, M., Tawa, R., Shibata, N., & Takada, K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.017 · Cited by 135
Human Tear pH: Diurnal Variations
Carney, L. G., & Hill, R. M. (1976) · Archives of Ophthalmology · doi:10.1001/archopht.1976.03910030405011 · Cited by 135
Thermodynamics, Molecular Mobility and Crystallization Kinetics of Amorphous Griseofulvin
Zhou, D., Zhang, G. G. Z., Law, D., Grant, D. J. W., & Schmitt, E. A. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800169g · Cited by 134
Ohara, T., Kitamura, S., Kitagawa, T., & Terada, K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.019 · Cited by 134
Thakur, R., & Gupta, R. B. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.11.005 · Cited by 134
Mou, D., Chen, H., Wan, J., Xu, H., & Yang, X. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.034 · Cited by 134
Arima, H., Yunomae, K., Miyake, K., Irie, T., Hirayama, F., & Uekama, K. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1025 · Cited by 134
Kossena, G. A., Charman, W. N., Boyd, B. J., Dunstan, D. E., & Porter, C. J. H. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10554 · Cited by 133
Self-citationLombardo, D., Fauvel, J., & Guy, O. (1980) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(80)90049-2 · Cited by 133
Fatouros, D. G., Deen, G. R., Arleth, L., Bergenståhl, B., Nielsen, F. S., Pedersen, J. S., & Müllertz, A. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9304-6 · Cited by 132
Current advances in sustained-release systems for parenteral drug delivery
Shi, Y., & Li, L. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.6.1039 · Cited by 132
Gershkovich, P., & Hoffman, A. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.07.011 · Cited by 132
A physicochemical Basis for the Effect of Food on the Absolute Oral Bioavailability of Halofantrine
Humberstone, A., Porter, C. J. H., & Charman, W. N. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950472p · Cited by 132
Self-citationInteraction of poloxamer block copolymers with cosolvents and surfactants
Ivanova, R. S., Alexandridis, P., & Lindman, B. (2001) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(01)00538-6 · Cited by 131
Mesoporous silicon: a platform for the delivery of therapeutics
Prestidge, C. A., Barnes, T. J., Lau, C.-H., Barnett, C., Loni, A., & Canham, L. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.2.101 · Cited by 131
Wu, X., Zhou, M., Huang, L., Wetterau, J. R., & Ginsberg, H. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.10277 · Cited by 131
Molecular Mobility of Supercooled Amorphous Indomethacin, Determined by Dynamic Mechanical Analysis
Andronis, V., & Zografi, G. (1997) · Pharmaceutical Research · doi:10.1023/a:1012026911459 · Cited by 130
Shell-crosslinked Pluronic L121 micelles as a drug delivery vehicle
Yang, T.-F., Chen, C., Chen, M., Lai, C.-H., Liang, H., & Sung, H. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.035 · Cited by 130
Non-crystalline solids: glasses and amorphous solids
Gupta, P. K. (1996) · Journal of Non-Crystalline Solids · doi:10.1016/0022-3093(95)00502-1 · Cited by 130
Scavenger Receptor Class B, Type I-mediated Uptake of Various Lipids into Cells
Thuahnai, S. T., Lund‐Katz, S., Williams, D. L., & Phillips, M. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106695200 · Cited by 129
Itraconazole in Cyclodextrin Solution
Stevens, D. A. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.8.603.31529 · Cited by 129
Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS)
Agarwal, V., Siddiqui, A., Ali, H., & Nazzal, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.08.046 · Cited by 129
Williams, H. D., Anby, M. U., Sassene, P. J., Kleberg, K., N’Goma, J. B., Calderone, M., Jannin, V., Igonin, A., Partheil, A., Marchaud, D., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300331z · Cited by 129
Self-citationGu, Y., Wang, G., Sun, J., Jia, Y., Wang, W., Xu, M., Lv, T., Zheng, Y., & Sai, Y. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.06.013 · Cited by 128
Webster, L. K., Linsenmeyer, M. E., Millward, M., Morton, C. G., Bishop, J. F., & Woodcock, D. M. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.20.1685 · Cited by 128
P-glycoprotein and surfactants: Effect on intestinal talinolol absorption
Bogman, K., Aschmann, Y. Z., DEGEN, L., Gérard Hopfgartner, D., Gutmann, H., Alsenz, J., & Drewe, J. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.09.001 · Cited by 126
Janssens, S., Zeure, A. D., Paudel, A., Humbeeck, J. V., Rombaut, P., & den Mooter, G. V. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0069-y · Cited by 126
Kadam, Y., Yerramilli, U., Bahadur, A., & Bahadur, P. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.10.041 · Cited by 126
The effects of Pluronic block copolymers on the aggregation state of nystatin
Croy, S., & Kwon, G. S. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.11.003 · Cited by 126
Fernandez, S., Jannin, V., Rodier, J.-D., Ritter, N., Mahler, B., & Carrière, F. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.009 · Cited by 126
Bioavailability of seocalcitol
Grove, M. F., Müllertz, A., Nielsen, J. L., & Pedersen, G. P. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.02.005 · Cited by 125
The effects of pharmaceutical excipients on drug disposition
Buggins, T. R., Dickinson, P. A., & Taylor, G. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.017 · Cited by 125
Miller, D. W., Batrakova, E. V., & Kabanov, A. V. (1999) · Pharmaceutical Research · doi:10.1023/a:1018873702411 · Cited by 124
Gao, Y., Li, Z., Sun, M. H., Li, H., Guo, C., Cui, J., Li, A., Cao, F., Xi, Y., Lou, H., et al. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639041003695139 · Cited by 124
Ganta, S., Paxton, J. W., Baguley, B. C., & Garg, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.022 · Cited by 122
The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers*
Chang, T. T., Benet, L. Z., & Hébert, M. F. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)80007-5 · Cited by 122
Gupta, S. K., Manfro, R. C., Tomlanovich, S. J., Gambertoglio, J. G., Garovoy, M. R., & Benet, L. Z. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb01868.x · Cited by 122
Abdalla, A., Klein, S., & Mäder, K. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.09.006 · Cited by 122
Black, D. D. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00189.2007 · Cited by 122
Kaukonen, A. M., Boyd, B. J., Charman, W. N., & Porter, C. J. H. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016283.87709.a9 · Cited by 121
Self-citationThe mechanism of the formation and secretion of chylomicrons
Kindel, T. L., Lee, D. M., & Tso, P. (2010) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2010.03.003 · Cited by 121
Six, K., Berghmans, H., Leuner, C., Dressman, J., Werde, K. V., Mullens, J., Benoist, L., Thimon, M., Meublat, L., Verreck, G., et al. (2003) · Pharmaceutical Research · doi:10.1023/a:1024414423779 · Cited by 120
Miyake, K., Arima, H., Hirayama, F., Yamamoto, M., Horikawa, T., Sumiyoshi, H., Noda, S., & Uekama, K. (2000) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100100556 · Cited by 120
Solubility Increases Associated with Crystalline Drug Nanoparticles: Methodologies and Significance
Eerdenbrugh, B. V., Vermant, J., Martens, J. A., Froyen, L., Humbeeck, J. V., den Mooter, G. V., & Augustijns, P. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100209b · Cited by 120
Sunesen, V. H., Vedelsdal, R., Kristensen, H. G., Christrup, L. L., & Müllertz, A. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.11.005 · Cited by 119
Study of pH-dependent solubility of organic bases. Revisit of Henderson-Hasselbalch relationship
Völgyi, G., Baka, E., Box, K. J., et al. (2010) · Analytica Chimica Acta · doi:10.1016/j.aca.2010.05.022 · Cited by 119
Ke, W., Li, J., Wang, W., et al. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21598 · Cited by 119
Meldrum, F. C., & Sear, R. P. (2008) · Science · doi:10.1126/science.1167221 · Cited by 118
Influence of different parameters on reconstitution of lyophilized SLN
Zimmermann, E., Müller, R. H., & Mäder, K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00424-x · Cited by 118
Prasad, Y. V. R., Puthli, S. P., Eaimtrakarn, S., et al. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00544-6 · Cited by 118
Mechanisms of chylomicron uptake into lacteals
Dixon, J. B. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05716.x · Cited by 118
The Utility of Sulfonate Salts in Drug Development
Elder, D. P., Delaney, E., Teasdale, A. J., Eyley, S., Reif, V. D., Jacq, K., Facchine, K. L., Oestrich, R. S., Sandra, P., & David, F. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22058 · Cited by 117
Ternary systems of naproxen with hydroxypropyl-β-cyclodextrin and aminoacids
Mura, P. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00265-5 · Cited by 116
Sachs‐Barrable, K., Thamboo, A., Lee, S. D., & Wasan, K. M. (2007) · PubMed · Cited by 116
Uptake of long-chain fatty acids in HepG2 cells involves caveolae
Pohl, J., Ring, A., & Stremmel, W. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m100404-jlr200 · Cited by 116
An examination of the factors affecting intestinal lymphatic transport of dietary lipids
Nordskog, B. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00147-8 · Cited by 116
Release and absorption rates of intramuscularly and subcutaneously injected pharmaceuticals (II)
Zuidema, J., Kadir, F., Titulaer, H. A. C., & Oussoren, C. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90103-1 · Cited by 115
Long-Chain Fatty Acid Uptake into Adipocytes Depends on Lipid Raft Function
Pohl, J., Ring, A., Ehehalt, R., Schulze‐Bergkamen, H., Schad, A., Verkade, P., & Stremmel, W. (2004) · Biochemistry · doi:10.1021/bi035743m · Cited by 115
Low Dose Lipid Formulations: Effects on Gastric Emptying and Biliary Secretion
Kossena, G. A., Charman, W. N., WILSON, C. G., O’Mahony, B., Lindsay, B., Hempenstall, J., Davison, C. L., Crowley, P., & Porter, C. J. H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9363-8 · Cited by 115
Self-citationLin, Y., Shen, Q., Katsumi, H., Okada, N., Fujita, T., Jiang, X., & Yamamoto, A. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1301 · Cited by 114
Shackleford, D. M., Faassen, W. A., Houwing, N. S., Lass, H., Edwards, G. A., Porter, C. J. H., & Charman, W. N. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052522 · Cited by 113
Self-citationMicellization of Hydrophobically Modified Cyclodextrins. 1. Micellar Structure
Auzély‐Velty, R., Djedaïni‐Pilard, F., Désert, S., Perly, B., & Zemb, T. N. (2000) · Langmuir · doi:10.1021/la991361z · Cited by 113
Lai, F., Sinico, C., Ennas, G., Marongiu, F., Marongiu, G., & Fadda, A. M. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.01.024 · Cited by 112
Animal models for the study of intestinal lymphatic drug transport
Edwards, G. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00148-x · Cited by 112
Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells
Maupas, C., Moulari, B., Béduneau, A., Lamprecht, A., & Pellequer, Y. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.03.056 · Cited by 111
Khoo, S., Edwards, G. A., Porter, C. J. H., & Charman, W. N. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1110 · Cited by 111
Self-citationPreparation and characterization of intravenously injectable curcumin nanosuspension
Gao, Y., Li, Z., Sun, M. H., Guo, C., Yu, A., Xi, Y., Cui, J., Lou, H., & Zhai, G. (2010) · Drug Delivery · doi:10.3109/10717544.2010.520353 · Cited by 111
Yoo, J.-S. H., Ning, S. M., Pantuck, C. B., Pantuck, E. J., & Yang, C. S. (1991) · Journal of Nutrition · doi:10.1093/jn/121.7.959 · Cited by 110
Moes, J. J., Koolen, S. L. W., Huitema, A. D. R., Schellens, J. H. M., Beijnen, J. H., & Nuijen, B. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.041 · Cited by 109
Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate
Ambrogi, V., Perioli, L., Marmottini, F., Giovagnoli, S., Esposito, M., & Rossi, C. R. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.07.005 · Cited by 109
Bottom-Up Preparation Techniques for Nanocrystals of Lipophilic Drugs
de Waard, H., Frijlink, H. W., & Hinrichs, W. L. J. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0323-3 · Cited by 109
Successful parenteral desensitization to paclitaxel
Essayan, D. M., Kagey‐Sobotka, A., Colarusso, P., Lichtenstein, L. M., Ozols, R. F., & King, E. D. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70281-6 · Cited by 109
Bhat, P. A., Dar, A. A., & Rather, G. M. (2008) · Journal of Chemical & Engineering Data · doi:10.1021/je700659g · Cited by 109
Effect of excipients on breast cancer resistance protein substrate uptake activity
Yamagata, T., Kusuhara, H., Morishita, M., Takayama, K., Benameur, H., & Sugiyama, Y. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.021 · Cited by 108
Preparation and characterization of intravenously injectable nimodipine nanosuspension
Xiong, R., Lu, W., Li, J., Wang, P., Xu, R., & Chen, T. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.08.036 · Cited by 108
Gupta, M. K., Tseng, Y., Goldman, D., & Bogner, R. H. (2002) · Pharmaceutical Research · doi:10.1023/a:1020905412654 · Cited by 107
High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate
Kojima, T., Tsutsumi, S., Yamamoto, K., Ikeda, Y., & Moriwaki, T. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.055 · Cited by 107
Salt form selection and characterization of LY333531 mesylate monohydrate
Engel, G. L., Farid, N. A., Faul, M. M., Richardson, L. A., & Winneroski, L. L. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00350-1 · Cited by 107
A New Understanding of the Relationship Between Solubility and Particle Size
Wu, W., & Nancollas, G. H. (1998) · Journal of Solution Chemistry · doi:10.1023/a:1022678505433 · Cited by 106
Larsen, A. T., Holm, R., Pedersen, M. L., & Müllertz, A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9641-0 · Cited by 106
Role of Salt and Excipient Properties on Disproportionation in the Solid-State
Guerrieri, P., & Taylor, L. S. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9918-y · Cited by 106
Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism
Hussain, M. M., Rava, P., Pan, X., Dai, K., Dougan, S. K., Iqbal, J., Lazare, F. B., & Khatun, I. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282feea85 · Cited by 106
Yamagata, T., Kusuhara, H., Morishita, M., Takayama, K., Benameur, H., & Sugiyama, Y. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.014217 · Cited by 106
Ribeiro, A. M., Figueiras, A., Santos, D. F. G., & Veiga, F. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-008-9143-8 · Cited by 104
Janssens, S., Nagels, S., de Armas, H. N., D’Autry, W., Schepdael, A. V., & den Mooter, G. V. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.11.004 · Cited by 104
Impregnation of PVP microparticles with ketoprofen in the presence of supercritical CO2
Manna, L., Banchero, M., Sola, D., et al. (2007) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2006.12.002 · Cited by 104
Iqbal, J., Anwar, K., & Hussain, M. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301177200 · Cited by 104
Biorelevant Dissolution Media Simulating the Proximal Human Gastrointestinal Tract: An Update
Jantratid, E., & Dressman, J. (2009) · Dissolution Technologies · doi:10.14227/dt160309p21 · Cited by 104
Heat capacity changes in glass-forming aqueous solutions and the glass transition in vitreous water
Angell, C. A., & Tucker, J. C. (1980) · The Journal of Physical Chemistry · doi:10.1021/j100440a009 · Cited by 103
Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450
Mountfield, R. J., Senepin, S., Schleimer, M., et al. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00586-x · Cited by 103
Micellar size, shape, and hydration of long-chain polyoxyethylene nonionic surfactants
Eini, D. I. D. E., Barry, B. W., & Rhodes, C. T. (1976) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(76)90314-3 · Cited by 103
Manjunath, K., & Venkateswarlu, V. (2006) · Journal of drug targeting · doi:10.1080/10611860600888850 · Cited by 103
pH–Solubility Profiles of Organic Carboxylic Acids and Their Salts
Chowhan, Z. T. (1978) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600670918 · Cited by 103
Hydrosols : alternatives for the parenteral application of poorly water soluble drugs
Gassmann, P., List, M., Schweitzer, A., & Sucker, H. (1994) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 103
Hees, T. J. V., Piel, G., Évrard, B., Otte, X., Thunus, L., & Delattre, L. (1999) · Pharmaceutical Research · doi:10.1023/a:1018955410414 · Cited by 102
An intravenous formulation decision tree for discovery compound formulation development
Lee, Y.-C., Zocharski, P., & Samas, B. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00704-4 · Cited by 102
Cyclodextrin complexation of NSAIDSs: physicochemical characteristics
Loftsson, Þ., Ólafsdóttir, B. J., Friđriksdóttir, H., & Jónsdóttir, S. (1993) · European Journal of Pharmaceutical Sciences · doi:10.1016/0928-0987(93)90023-4 · Cited by 101
Role of in vitro release models in formulation development and quality control of parenteral depots
Larsen, C., Larsen, S. W., Jensen, H. M., Yaghmur, A., & Østergaard, J. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903307431 · Cited by 101
Dependence of cycloamylose-substrate binding on charge
Bergeron, R. J., Channing, M. A., & McGovern, K. A. (1978) · Journal of the American Chemical Society · doi:10.1021/ja00477a051 · Cited by 101
Inclusion complexation of tolbutamide with β-cyclodextrin and hydroxypropyl-β-cyclodextrin
Veiga, F., Teixeira-Dias, J. J. C., Kedzierewicz, F., Sousa, A. F., & Maincent, P. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04243-1 · Cited by 100
The effect of different oils on the absorption of probucol in the rat
Palin, K. J., & WILSON, C. G. (1984) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1984.tb04919.x · Cited by 100
In vitroandin vivoevaluation of silybin nanosuspensions for oral and intravenous delivery
Wang, Y., Zhang, D., Liu, Z., Liu, G., Duan, C., Jia, L., Feng, F., Zhang, X., Shi, Y., & Zhang, Q. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/15/155104 · Cited by 100
Warren, D. B., Anby, M. U., Hawley, A. M., & Boyd, B. J. (2011) · Langmuir · doi:10.1021/la2011937 · Cited by 100
Brouwers, J., Tack, J. F., Lammert, F., & Augustijns, P. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20553 · Cited by 99
Ziller, K. H., & Rupprecht, H. (1988) · Drug Development and Industrial Pharmacy · doi:10.3109/03639048809152019 · Cited by 99
Lipid-based systems for the enhanced delivery of poorly water soluble drugs
Porter, C. J. H., Wasan, K. M., & Constantinides, P. P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.009 · Cited by 99
Self-citationSelf Association and Cyclodextrin Solubilization of NSAIDs
Magnusdottir, A., Másson, M., & Loftsson, Þ. (2002) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1023/a:1023079322024 · Cited by 99
Amorphous Drug Nanosuspensions. 2. Experimental Determination of Bulk Monomer Concentrations
Lindfors, L., Forssén, S., Skantze, P., et al. (2005) · Langmuir · doi:10.1021/la052367t · Cited by 98
Langguth, P., Hanafy, A., Frenzel, D., Grenier, P., Nhamias, A., Ohlig, T., Vergnault, G., & Spahn-Langguth, H. (2005) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-52182 · Cited by 98
Christiansen, A., Backensfeld, T., & Weitschies, W. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.07.005 · Cited by 98
Solubilization in Aqueous Micellar Systems
Mukerjee, P. (1979) · Springer eBooks · doi:10.1007/978-1-4615-7880-2_6 · Cited by 98
Recent advances in intravenous delivery of poorly water-soluble compounds
Shi, Y., Porter, W., Merdan, T., & Li, L. C. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903307423 · Cited by 97
Amorphous Ibuprofen Confined in Nanostructured Silica Materials: A Dynamical Approach
Brás, A. R. E., Merino, E. G., Neves, P. D., Fonseca, I. M., Dionísio, M. S., Schönhals, A., & Correia, N. T. (2011) · The Journal of Physical Chemistry C · doi:10.1021/jp107631m · Cited by 97
Maio, S. D., & Carrier, R. L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.034 · Cited by 96
Järvinen, T., Järvinen, K., Schwarting, N., & Stella, V. J. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840306 · Cited by 96
Absorption of oral progesterone is influenced by vehicle and particle size
Hargrove, J. T., Maxson, W. S., & Wentz, A. C. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90759-x · Cited by 95
Fate of β-Cyclodextrin in the Human Intestine
Flourié, B., Molis, C., Achour, L., Dupas, H., Hatat, C., & Rambaud, J. C. (1993) · Journal of Nutrition · doi:10.1093/jn/123.4.676 · Cited by 95
The effects of excipients on transporter mediated absorption
Goole, J., Lindley, D. J., Roth, W. J., Carl, S. M., Amighi, K., Kauffmann, J., & Knipp, G. T. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.019 · Cited by 94
Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40
Tayrouz, Y., Ding, R., Burhenne, J., Riedel, K., Weiß, J., Hoppe‐Tichy, T., Haefeli, W. E., & Mikus, G. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00059-6 · Cited by 94
Hanke, U., May, K. E., Rozehnal, V., Nagel, S., Siegmund, W., & Weitschies, W. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.008 · Cited by 94
Lipolysis of the semi-solid self-emulsifying excipient Gelucire® 44/14 by digestive lipases
Fernandez, S., Rodier, J.-D., Ritter, N., Mahler, B., Demarne, F., Carrière, F., & Jannin, V. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.05.006 · Cited by 93
Fernandez, S., Chevrier, S., Ritter, N., Mahler, B., Demarne, F., Carrière, F., & Jannin, V. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9906-2 · Cited by 93
The BCS, BDDCS, and Regulatory Guidances
Chen, M.-L., Amidon, G. L., Benet, L. Z., Lennernas, H., & Yu, L. X. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0438-1 · Cited by 93
Piel, G., Pirotte, B., Delneuville, I., Neven, P., Llabrès, G., Delarge, J., & Delattre, L. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960298k · Cited by 92
Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro
Christiansen, A., Backensfeld, T., Denner, K., & Weitschies, W. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.033 · Cited by 92
Gershkovich, P., & Hoffman, A. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.05.109 · Cited by 92
Lockwood, S. F., O'Malley, S. W., & Mosher, G. L. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10359 · Cited by 92
The potential use of cyclodextrins in parenteral formulations.
Brewster, M. E., Simpkins, J. W., Hora, M., et al. (1989) · PubMed · Cited by 91
Rapid dissolving high potency danazol powders produced by spray freezing into liquid process
Hu, J., Johnston, K. P., & Williams, R. O. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.11.003 · Cited by 91
The discovery of GSK221149A: A potent and selective oxytocin antagonist
Liddle, J., Allen, M. J., Borthwick, A. D., Brooks, D. P., Davies, D. E., Edwards, R. M., Exall, A. M., Hamlett, C. C. F., Irving, W. R., Mason, A. M., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.008 · Cited by 91
Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat‐meal rat models
Shayeganpour, A., Jun, A. S., & Brocks, D. R. (2005) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.457 · Cited by 91
Shono, Y., Jantratid, E., & Dressman, J. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.04.005 · Cited by 90
Cited by
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Khadka, P., Ro, J., Kim, H., Kim, I., Kim, J. T., Kim, H., Cho, J. M., Yun, G., & Lee, J. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.05.005 · Cited by 998
Baghel, S., Cathcart, H., & O'Reilly, N. J. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.10.008 · Cited by 970
Advances in Oral Drug Delivery
Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 876
The expanding role of prodrugs in contemporary drug design and development
Rautio, J., Meanwell, N. A., Di, L., & Hageman, M. J. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.46 · Cited by 767
Metadata
- Authors
- Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 65
- Issue
- 1
- Pages
- 315-499
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2133061394
- Cited by
- 1,570
- References
- 865
- FWCI
- 56.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.